Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Our vision declines as we age leading to the development of various eye conditions such as presbyopia cataracts and glaucoma ...